Mammographic Predictors of the Presence and Size of Invasive Carcinomas Associated with Malignant Microcalcification Lesions Without a Mass

American Journal of Roentgenology

Volumn 181, Issue 6, 2003, Pages 1679-1684

  Stomper, Paul C ^a   Geradts, Joseph ^a   Edge, Stephen B ^a   Levine, Ellis G ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CALCIFICATION; BREAST CARCINOMA; BREAST DUCT; BREAST TUMOR; CANCER DIAGNOSIS; CANCER SIZE; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREDICTION; PRIORITY JOURNAL;

EID: 0345275908     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.181.6.1811679     Document Type: Article

References (23)

1. Meyer JE, Eberlein TJ, Stomper PC, Sonnenfeld MR. Biopsy of occult breast lesions: analysis of 1261 abnormalities. JAMA 1990;263:2341-2343
2. Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Dershaw DD. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories. AJR 1998;171:35-40
3. Stomper PC, Winston JS, Proulx GM, Hurd TC, Edge SB. Mammographic detection and staging of ductal carcinoma in situ: mammographic-pathological correlation. Semin in Breast Dis 2000;3:2641
4. Stomper PC, Connolly JL. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. AJR 1992;159:483-485
5. Holland R, Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 1994;11:181-192
6. Tabar L, Gad A, Parsons WC, Neeland DB. Mammographic appearances of in situ carcinomas, In: Silverstein MJ, ed. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins, 1997:95-117
7. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2267-2274
8. Recht A, Rutgers EJ, Fentiman IS, Kurtz JM, Mansel RE, Sloane JP. The fourth EORTC DCIS consensus meeting (Chateau Marquette, Heemskerk, The Netherlands, 23-24 January 1998): conference report. Eur J Cancer 1998;34:1664-1669
9. Schwartz GF. Consensus conference on the classification of ductal carcinoma in situ: presented at the Consensus Conference on the Classification of Ductal Carcinoma in Situ, Philadelphia. Pennsylvania. April 25-28, 1998. Cancer 1997;80:1798-1802
10. Schnitt SJ, Connolly JL. Processing and evaluation of breast excision specimens: a clinically oriented approach. Am J Clin Pathol 1992;98:125-137
11. Waddell BE, Stomper PC, DeFazio JL, Hurd TC, Edge SB. Postexcision mammography is indicated after resection of ductal carcinoma in situ of the breast. Ann Surg Oncol 2000;7:665-668
12. Gluck BS, Dershaw DD, Liberman L, Deutch BM. Microcalcifications on postoperative mammograms as an indicator of adequacy of tumor excision. Radiology 1993;188:469-472
13. Compton CC, Henson DE, Hammond EH, Schramm JB. Reporting on cancer specimens: protocols and case summaries. Northfield, IL: College of American Pathologists, 1998:1-18
14. Fleming, ID, ed. AJCC staging manual, 5th ed., Philadelphia: Lippincott, Williams & Wilkins, 1997
15. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley, 1981:20-27
16. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ: relationship of extent of non-invasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50:1309-1314
17. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-624
18. Egan RL, Ellis JT, Powell RW. Team approach to the study of diseases of the breast. Cancer 1969;23:847-854
19. Cox CE, Nguyen K, Gray RJ, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001;67:513-519
20. Silverstein MJ, Rosser RJ, Gierson ED, et al. Axillary lymph node dissection for intraductal breast carcinoma: is it indicated? Cancer 1987;59:1819-1824
21. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Ann Surg Oncol 2000;7:636-642
22. Lagios MD, Silverstein MJ. Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol 2001;8:275-277
23. Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001;218:497-502